pharma Β· Asthma Β· Type 2 Diabetes
AstraZeneca
AstraZeneca clinical programs β 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridgeshire CB2 0AA, GB
- Employees
- 79,242
- Programs
- 129
- Drugs
- 77
- Patents
- 25
AstraZeneca projects
6 ClinicalTrials.gov programs sponsored by AstraZeneca.
AstraZeneca has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AZD1222
AstraZeneca
COVID-19, SARS-CoV-2
1 trial -
D9311L00001
AstraZeneca
Advanced or recurrent endometrial cancer
1 trial -
Dapagliflozin
AstraZeneca
Diabetes Mellitus, Type 2
1 trial -
Durvalumab
AstraZeneca
Solid Tumor
1 trial -
Symbicort Turbuhaler (budesonide/formoterol) 320/9 ΞΌg
AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
Symbicort Turbuhaler 160/4.5
AstraZeneca
Asthma
1 trial
Frequently asked questions
How many clinical projects does AstraZeneca have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.